表紙
市場調查報告書

微針頭藥物輸送設備市場:∼2024年

Microneedle Drug Delivery Devices to 2024

出版商 Greystone Research Associates 商品編碼 928858
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
微針頭藥物輸送設備市場:∼2024年 Microneedle Drug Delivery Devices to 2024
出版日期: 2020年03月17日內容資訊: 英文
簡介

本報告提供微針頭藥物輸送設備的市場調查,產品概要,市場現狀,材料及技術趨勢,各種尺寸規格,商業化的推動因素,各種倡議、計劃,主要疾病的市場機會,進入經營者的簡介等彙整資料。

目錄

  • 摘要整理
  • 微針頭:現狀
  • 微針頭:需求推動因素
  • 人口統計
  • 慢性症狀
  • 患者的自我護理
  • 管理式護理計劃
  • 微針頭陣列&陣列幾何學
  • 微針頭設備技術
  • 材料選擇
  • pH響應性共聚物
  • 製造法
    • 微成型
    • 微機械加工
    • 結構化薄膜
  • 新的製造法
    • 積層製造
    • 噴墨印刷
    • 3D列印
    • 電墩距陣列
    • 電塗裝
    • 磁化引起
    • 自我集合
  • 陣列架構
  • 微針頭的尺寸規格
    • 固型微針頭
    • 被覆微針頭
    • 中空微針頭
    • 奈米碳管
    • 離子蝕刻
    • C-MEMS
    • 電解質感測
    • 溶解性微針頭
    • 水凝膠
    • 伸縮性針頭
    • 緩釋性微針頭
    • 絲微針頭
    • 注射器安裝型微針頭
    • 特殊微針頭
    • 相變
    • 複合材料微針頭
    • 微處理器為基礎的設備
    • 複合材料微針頭
    • 光響應性微針頭
    • 彈性陣列
    • 微針頭和微流體
    • 穿戴式微針頭
  • 微針頭設備的商業化推動因素
  • 體外公佈實驗
  • 用途
  • 容器施栓、穩定性
  • 微針頭開發倡議
  • NPO、NGO
  • COE (Center of Excellence)
  • Gates Foundation
  • 政府倡議
  • 政府技術轉移計劃
    • 歐洲
    • 日本
    • 北美
  • 學術計劃
    • 英國
    • 韓國
    • 荷蘭
    • 日本
    • 愛爾蘭
    • 瑞典
    • 澳洲
    • 義大利
  • 市場、市場機會
    • 遺傳基因/DNA/核苷酸治療
    • nRNA
    • 免疫療法
    • HIV
    • 代謝性疾病
    • 糖尿病
    • 神經科
    • 偏頭痛
    • 骨質疏鬆症
    • 癌症
    • 疫苗
    • 預防疫苗
    • 疫苗接種數量的節約
    • 肽治療
  • 進入經營者的簡介
目錄
Product Code: MDD292F

Microneedle technology is attaining commercial viability at a time when drug developers are faced with new challenges as they assess ways to administer new classes of compounds with significant therapeutic potential. The widespread availability of rapid throughput screening is accelerating the discovery of new drugs, a significant number of which are large-molecule therapeutic compounds that cannot tolerate passage through the digestive system, requiring pharmaceutical companies to forego oral formulations and select alternate routes of administration. Microneedle technology has the potential address the growing trend toward self-administration by allowing the precise placement of therapeutic agents at prescribed locations below the skin. To succeed, developers must refine the techniques for large-scale manufacturing and advance the design integration of microneedles into commercially viable drug delivery systems.

What Your Will Learn:

  • What approved drug products are currently supplied in microneedle devices and systems, what are the device specifics, and who markets them?
  • Who are the branded microneedle drug delivery device and system suppliers, their manufacturing infrastructure and locations, their capabilities?
  • What are the major factors that are influencing demand for microneedle drug delivery?
  • How important are drug developer-device manufacturer relationships and what are the key alliances in the industry?
  • What are the essential design factors, material selection issues, technologies and market development issues for microneedle drug delivery products?
  • What are the important therapeutic markets for microneedle delivery products and what is their market share now? What will it be in 2024?
  • What are the significant economic, technology, and regulatory factors affecting the market for microneedle drug delivery systems?

Table of Contents

  • Executive Summary
  • Microneedles - Where we are today
  • Microneedle Demand Drivers
  • Population Demographics
  • Chronic Conditions
  • Patient Self-care
  • Managed Care Initiatives
  • Microneedle Arrays & Array Geometries
  • Microneedle Device Technology
  • Material Selection
  • pH-responsive Co-polymers
  • Fabrication Methods
  • Microforming
  • Micromachining
  • Structured Films
  • Emerging Fabrication Methods
  • Additive Manufacturing
  • InkJet Printing
  • 3D Printing
  • Electrospun Arrays
  • Electrodeposition
  • Magnetization-induced
  • Self-assembly
  • Array Architectures
  • Microneedle Form Factors
  • Solid Microneedles
  • Coated Microneedles
  • Hollow Microneedles
  • Carbon Nanotubes
  • Ion Etching
  • C-MEMS
  • Electrolyte Sensing
  • Dissolving Microneedles
  • Hydrogels
  • Stretched Needles
  • Sustained Release Microneedles
  • Silk Microneedles
  • Syringe-mounted Microneedles
  • Specialty Microneedles
  • Phase Transition
  • Composite Microneedles
  • Microprocessor-based Devices
  • Composite Microneedles
  • Light-responsive Microneedles
  • Flexible Arrays
  • Microneedles & Microfluidics
  • Wearable Microneedles
  • Microneedle Device Commercialization Factors
  • In Vitro Release Testing
  • Intended Use
  • Container Closure and Stability
  • Microneedle Development Initiatives
  • Non-Profits/NGOs
  • PATH Center of Excellence for Microarray Patch Technology
  • Gates Foundation
  • Government Initiatives
  • Government Technology Transfer Programs
  • Europe
  • Japan
  • North America
  • Academic Programs
  • United Kingdom
  • South Korea
  • Netherlands
  • Japan
  • Ireland
  • Sweden
  • Australia
  • Italy
  • Markets and Opportunities
  • Genetic/DNA/Nucleotide Therapeutics
  • nRNA
  • Imunotherapeutics
  • HIV
  • Metabolic
  • Diabetes
  • Neurology
  • Migraine
  • Osteoporosis
  • Oncology
  • Vaccines
  • Prophylactic Vaccines
  • Vaccine Dose Sparing
  • Therapeutic Peptides
  • Market Participant Profiles